Three A Research
Three A Research
El Paso, Texas, United States1 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR) | Papulopustular Rosacea, Skin and Connective Tissue Diseases, primary hyperoxaluria type 2, rosacea, skin disorder | Recruiting | Phase 2 | 2026-09-28 | NCT07681271 |